Skip to main content
. 2017 Nov 6;145(16):3370–3374. doi: 10.1017/S0950268817002412

Table 3.

Summary of the studies that assessed HEV seropositivity in MSM subjects in Europe

Study Years Country Assay Population Samples (n) Prevalence in MSM as compared with controls Odds ratio for HEV seropositivity in MSM (95% CI)
Payne et al. [15] 2008 UK Wantai HIV-negative men 422 10·4% in MSM vs. 3·5% in heterosexuals 3·1
Lanini et al. [14] 2002–2011 Italy Dia. pro Subjects that underwent HIV testing and counseling 1116 Not reported 1·9 (1·03–3·5)
Keane et al. [19] 2009–2010 UK Wantai HIV-infected subjects 138 Not reported 0·36 (0·09–1·34)
Pineda et al. [18] 2009 Spain Wantai HIV-infected subjects 613 Not reported 1·55 (0·86–2·78)
Present study 2014–2016 Belgium Wantai Subjects attending a STI clinic with a HIV test performed 576 8·9% in MSM vs. 9·1% in heterosexuals 0·98 (0·53–1·82)